Vanguard Reports 0% Stake in Tenet Healthcare
The Vanguard Group filed Amendment No. 16 to a Schedule 13G/A reporting 0 shares and 0% beneficial ownership of Tenet Healthcare Corp common stock as part of an internal realignment described under SEC Release No. 34-39538.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 16 to a Schedule 13G/A reporting 0 shares and 0% beneficial ownership of Tenet Healthcare Corp common stock as part of an internal realignment described under SEC Release No. 34-39538.
The filing states certain Vanguard subsidiaries will report beneficial ownership separately after the realignment dated 01/12/2026, and that The Vanguard Group, Inc. no longer is deemed to beneficially own securities held by those subsidiaries. The form is signed by Ashley Grim on 03/27/2026.
Insights
Vanguard reports no direct stake in Tenet after internal reorganization.
The filing documents an internal disaggregation: Vanguard entities that previously reported through The Vanguard Group will now report separately in reliance on SEC Release No. 34-39538. The disclosed beneficial ownership for The Vanguard Group in Tenet is 0 shares and 0%.
Practical implication: reported ownership metrics for Tenet may shift across multiple Vanguard-related filings going forward; sample follow-up items include new Schedule 13G/A entries from Vanguard affiliates showing per-entity holdings.
Amendment reflects a reporting allocation change, not a market trade.
The statement cites internal realignment and reliance on SEC Release No. 34-39538 to report beneficial ownership on a disaggregated basis. The form explicitly lists 0 for sole/shared voting and dispositive power for The Vanguard Group.
Compliance note: investors should track subsequent 13G/A filings from Vanguard subsidiaries for where the actual holdings are reported; cash-flow treatment is not stated in this excerpt.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Schedule 13G/A amendment say about Vanguard's stake in Tenet (THC)?
Why does Vanguard report zero ownership after the internal realignment?
When was the amendment signed and who signed it?
AI-generated analysis. How Rhea-AI works. Not financial advice.